Back
16 February 2022
The Adverse Analytical Finding (AAF)1 returned for the non-specified prohibited substance mesterolone metabolite 3α-hydroxy-1α-methyl-5α-androstan-17-one (classified as S1. Anabolic Androgenic Steroid) and the specified prohibited substances 5-methylhexan-2-amine and heptaminol (classified as S6. Stimulants according to the Prohibited List of the World Anti-Doping Agency (WADA)).
The sample was collected by the ITA under the testing authority and results management authority of the International Olympic Committee (IOC) during an in-competition anti-doping control on 10 February 2022 in Zhangjiakou, China. The result was reported by the WADA-accredited laboratory of Beijing on 15 February 20222.
The athlete has been informed of the case and has been provisionally suspended until the resolution of the matter in line with the World Anti-Doping Code and the IOC Anti-Doping Rules applicable to the Olympic Winter Games Beijing 2022. This means that the athlete is prevented from competing, training, coaching, or participating in any activity, during the Olympic Winter Games Beijing 2022.
The athlete has the right to challenge the imposition of the provisional suspension before the Court of Arbitration for Sport – Anti-Doping Division (CAS ADD).
The athlete also has the right to request the analysis of the B-sample.
Given that the case is underway, there will be no further comments during the ongoing proceeding.
1: A report from a WADA-accredited laboratory that, consistent with the International Standard for Laboratories, establishes in a Sample the presence of a Prohibited Substance or its Metabolites or Markers or evidence of the Use of a Prohibited Method.
2: During the Olympic Winter Games Beijing 2022, a fast turnaround of samples from the WADA-accredited laboratory of Beijing is implemented and samples are usually analysed and results reported in less than 48 hours. Considering that the sample at stake contains multiple banned substances, the analytical work required additional time.
